Trade WVE stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Wave Life Sciences, Inc. (WVE) is trading at US$3.13, down 1.88% today as of Oct 16, 16:00 EDT. The company has a market capitalisation of US$1.04B. Over the past 52 weeks, WVE has traded between US$3.04 and US$21.73. On Syfe you can trade WVE with $0 commission and add it to your watchlist.
| Previous close | US$3.19 |
|---|---|
| Market cap | US$1.04B |
| 52-week range | US$3.04 – US$21.73 |
| Volume | 3.28M |
| Exchange | US |
Wave Life Sciences, Inc.
Wave Life Sciences, Inc. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It develops and commercializes a pipeline of RNA medicines across a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Cambridge, MA.
Year: 2015
Wave Life Sciences, Inc. (WVE) stock is trading at US$3.13, -1.88% from the previous close of US$3.19.
The market cap for Wave Life Sciences, Inc. (WVE) stock is approximately US$1.04B.
The 52-week high for Wave Life Sciences, Inc. (WVE) stock is US$21.73.
The 52-week low for Wave Life Sciences, Inc. (WVE) stock is US$3.04.
Wave Life Sciences, Inc. (WVE) does not currently pay a dividend.
Stay on top of WVE
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
